ContributorsPublishersAdvertisers

Is The Pullback In Moderna's Stock A Buying Opportunity?

Benzinga
 2021-10-15

Cover picture for the articleModerna Inc (NASDAQ:MRNA) turned sharply lower Friday following reports that the Food and Drug Administration is delaying a decision on authorizing the company's COVID-19 vaccine for adolescents. The delay will give the FDA time to assess if ther vaccine could help lead to a heightened risk of a rare inflammatory heart...

www.benzinga.com

Comments / 0

Comments / 0